Maintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737140.6.1.141
Reference89 articles.
1. Cancer Statistics, 2005
2. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden
3. Rising Incidence of Renal Cell Cancer in the United States
4. THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA
5. Uzzo RG, Rayman P, Novick AC, Bukovski RM, Finle JH. Molecular mechanisms of immune dysfunction in renal cell carcinoma. In: Bukowski RM, Novick AC (Eds.)Renal Cell Carcinoma: Molecular Biology, Immunology and Clinical Management. Humana Press, NJ, USA, 63–78 (2000).
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer;Cancer Immunology, Immunotherapy;2009-09-25
2. Cytokine-Based Immunotherapy for Advanced Kidney Cancer: Past Results and Future Perspectives in the Era of Molecularly Targeted Agents;The Scientific World JOURNAL;2007
3. Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors;Expert Opinion on Biological Therapy;2006-12-06
4. Integrated non-invasive system for quantifying secreted human therapeutic hIL2;Biotechnology and Bioengineering;2006
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3